Present
Chief Financial Officer
Valore Group, Inc.
Nathan leads Valore's financial strategy, capital planning, controllership, and investor reporting, building the financial infrastructure to support the company's growth and multi-entity platform.
Leadership
Nathan Smith
Chief Financial Officer
Salt Lake City, Utah
Nathan Smith is Chief Financial Officer of Valore Group. He brings more than twenty-three years of finance leadership across high-growth private and publicly traded healthcare and life sciences organizations, having raised over $850 million in equity and debt and scaled finance organizations from 15 to more than 200 employees. He is currently CFO of Win Brands Group (Costa Vida and FatCats) and has previously served as CFO of Inmedix, Inc., CareDx, Inc., Mountain Land Physical Therapy, and Blackrock Neurotech, with earlier finance, treasury, investor-relations, and controller roles at Myriad Genetics and as an Audit Manager at Ernst & Young. Nathan pairs deep capital-markets, SEC-reporting, SOX, M&A, and IPO-readiness experience with an operator's instinct for building the systems and teams that let ambitious healthcare companies scale with discipline — a fit for Valore's mission to make continuous, patient-centered care both viable and durable.
View LinkedInFocus areas
- Capital markets, equity and debt fundraising
- SEC reporting, SOX compliance, and audit readiness
- M&A execution and IPO preparation
- Finance-team build-out and operational scaling
- Healthcare and life sciences finance leadership
Experience
Present
Chief Financial Officer
Win Brands Group (Costa Vida / FatCats)
Oversees finance and accounting for a multi-brand consumer platform, leading capital strategy, reporting, and operating discipline across the portfolio.
Prior
Chief Financial Officer
Inmedix, Inc.; CareDx, Inc.; Mountain Land Physical Therapy; Blackrock Neurotech
Led finance across a series of high-growth private and publicly traded healthcare and life sciences companies, including capital raises, SEC reporting, SOX implementation, M&A, and IPO preparation.
Prior
Finance, Treasury, Investor Relations, Controller
Myriad Genetics
Held progressive finance leadership roles at a publicly traded genetic-testing pioneer, supporting capital-markets activity and financial operations at scale.
Prior
Audit Manager
Ernst & Young
Managed audit engagements for public and private clients, building the technical accounting and controls foundation that has anchored his CFO career.